Iosat

   
Google
 
Web NewDrugInformation.com

Iosat


Drug - Iosat
The trade name of the product as shown on the labeling.

Dosage - TABLET; ORAL
The product dosage form and route separated by a semi-colon.

Active Ingredient(s) - Potassium Iodide
Multiple ingredients are in alphabetical order.

Strength - 130MG
The potency of the active ingredient(s), Potassium Iodide. May repeat for multiple part products.

Applicant - ANBEX
The firm name holding legal responsibility for Iosat. The firm name is condensed to a maximum twenty character unique string.

New Drug Application (NDA) Number - 018664
The FDA assigned number to Iosat. Format is nnnnnn.

Product Number - 001
The FDA assigned number to identify Iosat. Each strength is a separate product. May repeat for multiple part products. Format is nnn.

Therapeutic Equivalence (TE) Code -
The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products.

Approval Date - Oct 14, 1982
The date Iosat was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982".

Reference Listed Drug (RLD) - Yes
The pioneer or innovator of Iosat. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No.

Type - OTC
The group or category of approved drugs Iosat is in. Format is RX, OTC, DISCN.

Applicant Full Name - Anbex Inc
The full name of the firm holding legal responsibility for the new application of Iosat.

Iosat